NCM · Financial Statements

CalciMedica, Inc. (CALC) Revenue, Earnings & Financial Statements

$1.22 NCM: CALC Market Cap $3.84M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

CalciMedica, Inc. most recently reported annual revenue of $0, a net loss of $30.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

CalciMedica, Inc.: net profit was positive in 0 of 8 reported years; the most recent year shows a net loss of $30.0M.

Income Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Revenue$0$0$0$0$0$0$0$0
Operating Expenses$29.0M$38.0M$30.0M$36.0M$14.0M$38.0M$24.0M$23.0M
Operating Profit−$29.0M−$38.0M−$30.0M−$36.0M−$14.0M−$38.0M−$24.0M−$23.0M
Other Income$0$0$2.0M$0$6.0M$4.0M$11.0M−$6.0M
Interest$0$0$0$0$0$0$0$1.0M
Depreciation$0$0$0$1.0M$0$0$0$0
Profit Before Tax−$28.0M−$37.0M−$28.0M−$36.0M−$8.0M−$34.0M−$14.0M−$30.0M
Tax rate (%)-0.1%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$28.0M−$37.0M−$28.0M−$36.0M−$8.0M−$34.0M−$14.0M−$30.0M
EPS−$165.50−$179.25−$367.50−$118.30−$116.00−$38.25−$6.10−$9.85

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Operating Expenses$4.0M$6.0M$7.0M$6.0M$6.0M$6.0M$7.0M$6.0M$4.0M$6.0M$4.0M$5.0M
Operating Profit−$4.0M−$6.0M−$7.0M−$6.0M−$6.0M−$6.0M−$7.0M−$6.0M−$4.0M−$6.0M−$4.0M−$5.0M
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$4.0M$0−$4.0M−$6.0M−$4.0M−$5.0M−$6.0M−$8.0M−$11.0M$5.0M−$8.0M−$2.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$4.0M$0−$4.0M−$6.0M−$4.0M−$5.0M−$6.0M−$8.0M−$11.0M$5.0M−$8.0M−$2.0M
EPS−$3.60$0.06−$1.80−$2.50−$1.65−$1.80−$2.00−$2.60−$3.60$1.50−$2.25−$0.24

Over the 8 years reported for CalciMedica, Inc., borrowings decreased from $79.0M in 2018 to $10.0M in 2025, cash stood at $12.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.50 times.

Balance Sheet — 8 Years (USD millions)

Metric20182019202020212022202320242025
Total Assets$18.0M$41.0M$102.0M$69.0M$3.0M$12.0M$20.0M$14.0M
Current Assets$13.0M$36.0M$99.0M$67.0M$2.0M$12.0M$20.0M$14.0M
Cash$13.0M$16.0M$33.0M$13.0M$1.0M$6.0M$8.0M$12.0M
Inventory$0$0$0$0$0$0$0$0
Receivables$0$0$0$0$0$0$0$0
Fixed Assets$2.0M$2.0M$2.0M$2.0M$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0$0$0
Investments$0$20.0M$62.0M$50.0M$0$6.0M$11.0M$1.0M
Other Assets$0$0$0$0$0$0$0$0
Total Liabilities$6.0M$12.0M$7.0M$4.0M$13.0M$4.0M$5.0M$20.0M
Current Liabilities$6.0M$12.0M$7.0M$4.0M$5.0M$4.0M$4.0M$4.0M
Borrowings$79.0M$131.0M$0$0$5.0M$0$0$10.0M
Other Liabilities$0$0$7.0M$4.0M$7.0M$4.0M$5.0M$11.0M
Equity$0$0$0$0$0$0$0$0
Reserves$12.0M$28.0M$95.0M$65.0M−$9.0M$8.0M$14.0M−$7.0M

For CalciMedica, Inc., operating cash flow was positive in 0 of 8 reported years; free cash flow in the latest year was negative at $21.0M; free cash flow was positive in 0 of 8 years.

Cash Flow Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Operating Cash Flow−$28.0M−$31.0M−$32.0M−$31.0M−$12.0M−$26.0M−$21.0M−$21.0M
Investing Cash Flow−$3.0M−$21.0M−$44.0M$10.0M$0$9.0M−$4.0M$10.0M
Financing Cash Flow$0$0−$4.0M$0$0−$5.0M$0$0
Net Cash Flow$12.0M$3.0M$18.0M−$20.0M−$3.0M$4.0M$2.0M$4.0M
Free Cash Flow−$30.0M−$32.0M−$33.0M−$32.0M−$12.0M−$26.0M−$21.0M−$21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA0.05
FCF Yield-466.05%
Quick Ratio4.96
Interest Coverage-14.15
Return 1Y-92.24%
Return 3Y-92.99%
Return 5Y—

CalciMedica, Inc. (CALC) financials — frequently asked questions

What is CalciMedica, Inc.'s annual revenue?

CalciMedica, Inc. (CALC) reported annual revenue of $0 in its most recent fiscal year.

What is CalciMedica, Inc.'s net profit?

CalciMedica, Inc. (CALC) reported a net loss of $30.0M in its most recent fiscal year.

What is CALC EV/EBITDA?

CalciMedica, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 0.05.

Revenue and earnings of other Biotechnology stocks

VRTX revenue $12.1BREGN revenue $14.3BMRNA revenue $1.9BRVMD financialsROIV revenue $8.0MINSM revenue $606.0MUTHR revenue $3.2BINCY revenue $5.1BALNY revenue $3.7BASND revenue $692.0MAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
CALC Overview CALC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.